問卷

TPIDB > Search Result

Search Result

篩選

List

3348Cases

2017-01-01 - 2024-06-12

Phase I/II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Terminated2Sites

2018-03-20 - 2024-03-31

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
9Sites

Terminated9Sites

2023-09-01 - 2023-12-31

Phase I/II

Completed
A Phase 1/2 Open Label, Multicenter, Dose Escalation and Expansion Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM43239 in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
  • Condition/Disease

    Leukemia, Myeloid, Acute

  • Test Drug

    Film coated Tablets

Participate Sites
3Sites

Terminated3Sites

2020-05-01 - 2022-12-25

Phase I

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Terminated2Sites

2022-09-30 - 2027-04-30

Phase II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Recruiting4Sites

2017-10-18 - 2019-12-31

Phase II

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Terminated2Sites

2017-05-05 - 2019-12-31

Others

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Terminated1Sites

2017-05-31 - 2018-12-31

Others

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Terminated1Sites

2023-02-01 - 2025-12-31

Phase II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Recruiting1Sites